ask our doctors

Anemia Of Chronic Disease

Get the facts on Anemia Of Chronic Disease treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Anemia Of Chronic Disease prevention, screening, research, statistics and other Anemia Of Chronic Disease related topics. We answer all your qestions about Anemia Of Chronic Disease.

Question: Why do ferritin increase in anemia of chronic disease? Thanks alot...very clear explanation!!

Answer: In anemia of chronic disease without iron deficiency, ferritin levels are normal or high, reflecting the fact that iron is stored within cells, and ferritin is being produced as an acute phase reactant but the cells are not releasing their iron. Iron is not utilized because there is less erythropoiesis (formation of red blood cells & hemoglobin). Thus to store the unused iron, ferritin protein that binds this iron is produced in increased amount. I hope I could make it clear. Good luck!


Anemia Of Chronic Disease News

Renal and Urology News

Exercise Enhances Body Composition, Nutritional Status in Dialysis Patients
Renal and Urology News
 

Medgenics Adds Two Key Opinion Leaders to Strategic Advisory Board

MarketWatch (press release)
He has spoken nationally and internationally on chronic liver disease and received many awards, including the American Liver Foundation Award for Excellence and the Mitchell Lectureship of the Royal College of Physicians. He is a member of the American ...
 

AMAG Pharmaceuticals Announces Completion of Enrollment in its Phase III ...

MarketWatch (press release)
Feraheme is indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease. Feraheme is contraindicated in patients with known hypersensitivity to Feraheme or any of its components.
 

Affymax Promotes Cynthia Smith to Vice President, Market Access and Commercial ...

MarketWatch (press release)
... access strategies will be invaluable to our success as we prepare for the potential approval and commercialization of peginesatide, an investigational drug under FDA review for the treatment of anemia in chronic kidney disease patients on dialysis.
 

Art, Jazz, Poetry at the Soul n Luv Art Show to benefit CASA, February 4th, 2012

Examiner.com
Reese is a very determined person, and she has to be, as a lifelong sufferer of Sickle Cell Anemia, a chronic disease that is hereditary. It causes Reese joint pain, like really bad arthritus pain, and it can continue constantly if medical treatment is ...
 

Affymax Promotes Cynthia Smith to Vice President, Market Access and Commercial ...

EON: Enhanced Online News (press release)
... access strategies will be invaluable to our success as we prepare for the potential approval and commercialization of peginesatide, an investigational drug under FDA review for the treatment of anemia in chronic kidney disease patients on dialysis.
 

Did You Buy These Stocks?

NASDAQ
Ltd. for the treatment of anemia in chronic kidney disease patients on dialysis. The drug candidate is under FDA review. Last month, an FDA panel voted in favor of benefit/risk profile for Peginesatide, and the regulatory agency's final decision is set ...
 

NOLA.com

Severe Anemia Potent Predictor of Death After Stroke
Medscape
 

Medgenics Sets Record Date for 2012 Annual Meeting of Stockholders

MarketWatch (press release)
... a proprietary tissue-based platform technology for the sustained production and delivery of therapeutic proteins using the patient's own skin biopsy for the treatment of a range of chronic diseases including anemia, hepatitis C and hemophilia.
 

Glance: Diseases targeted by Gates Foundation push

BusinessWeek
By AP --Guinea worm disease, infection by nematode worms growing up to 3 feet in length. It's transmitted by drinking water, and the female worm eventually emerges painfully through skin. --Leprosy, or Hansen's Disease. A bacterial infection, it causes ...